chr16-30899509-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001330.5(CTF1):c.120C>T(p.Tyr40Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00394 in 1,604,656 control chromosomes in the GnomAD database, including 211 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.022 ( 109 hom., cov: 31)
Exomes 𝑓: 0.0021 ( 102 hom. )
Consequence
CTF1
NM_001330.5 synonymous
NM_001330.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.292
Publications
2 publications found
Genes affected
CTF1 (HGNC:2499): (cardiotrophin 1) The protein encoded by this gene is a secreted cytokine that induces cardiac myocyte hypertrophy in vitro. It has been shown to bind and activate the ILST/gp130 receoptor. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
CTF1 Gene-Disease associations (from GenCC):
- dilated cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant 16-30899509-C-T is Benign according to our data. Variant chr16-30899509-C-T is described in ClinVar as Benign. ClinVar VariationId is 44172.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.292 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0731 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0215 AC: 3245AN: 150764Hom.: 110 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
3245
AN:
150764
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00568 AC: 1415AN: 248914 AF XY: 0.00410 show subpopulations
GnomAD2 exomes
AF:
AC:
1415
AN:
248914
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00212 AC: 3076AN: 1453762Hom.: 102 Cov.: 31 AF XY: 0.00174 AC XY: 1259AN XY: 723270 show subpopulations
GnomAD4 exome
AF:
AC:
3076
AN:
1453762
Hom.:
Cov.:
31
AF XY:
AC XY:
1259
AN XY:
723270
show subpopulations
African (AFR)
AF:
AC:
2536
AN:
33272
American (AMR)
AF:
AC:
143
AN:
44418
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25910
East Asian (EAS)
AF:
AC:
0
AN:
39330
South Asian (SAS)
AF:
AC:
18
AN:
86076
European-Finnish (FIN)
AF:
AC:
0
AN:
52838
Middle Eastern (MID)
AF:
AC:
7
AN:
5734
European-Non Finnish (NFE)
AF:
AC:
103
AN:
1106232
Other (OTH)
AF:
AC:
269
AN:
59952
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
131
263
394
526
657
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
82
164
246
328
410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0215 AC: 3245AN: 150894Hom.: 109 Cov.: 31 AF XY: 0.0211 AC XY: 1551AN XY: 73664 show subpopulations
GnomAD4 genome
AF:
AC:
3245
AN:
150894
Hom.:
Cov.:
31
AF XY:
AC XY:
1551
AN XY:
73664
show subpopulations
African (AFR)
AF:
AC:
3093
AN:
41052
American (AMR)
AF:
AC:
101
AN:
15112
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3460
East Asian (EAS)
AF:
AC:
0
AN:
5084
South Asian (SAS)
AF:
AC:
1
AN:
4730
European-Finnish (FIN)
AF:
AC:
0
AN:
10348
Middle Eastern (MID)
AF:
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
AC:
24
AN:
67816
Other (OTH)
AF:
AC:
21
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
145
290
434
579
724
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
11
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
May 05, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
Dec 04, 2008
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Cardiomyopathy Benign:1
Jun 14, 2016
CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Dilated Cardiomyopathy, Dominant Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.